DAPERB 3,4-DiAminoPyridine

null · null

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DAPERB 3,4-DiAminoPyridine, covering 2020-12-07 to 2020-12-07. Get the full timeline:

Most recent: Clinical Trial Update: DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome [Phase 3]